Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,402.76 -22.09 -0.13%
S&P 500 1,863.96 1.65 0.09%
NASDAQ 4,086.17 -0.06 -0.00%
Ticker Volume Price Price Delta
STOXX 50 3,156.35 17.09 0.54%
FTSE 100 6,625.29 41.12 0.62%
DAX 9,414.47 96.65 1.04%
Ticker Volume Price Price Delta
NIKKEI 14,417.53 -0.15 -0.00%
TOPIX 1,166.59 0.04 0.00%
HANG SENG 22,760.24 64.23 0.28%

Bosch Healthcare Reacquires the Rights to Its Patents in the Diabetes Field from Abbott



  Bosch Healthcare Reacquires the Rights to Its Patents in the Diabetes Field
  from Abbott

  * Diabetes impacts millions of Americans each day
  * Bosch Healthcare offers licenses under its extensive patent portfolio to
    enable remote patient monitoring and management in chronic conditions,
    including diabetes

Business Wire

PALO ALTO, Calif. -- August 23, 2013

Robert Bosch Healthcare Systems, Inc. (Bosch Healthcare) announced today an
agreement with Abbott's diabetes care business for a non-exclusive license
under select Bosch Healthcare patents, for use in the diabetes field,
following the termination of a previously established exclusive license
agreement. As a result of these actions, Bosch Healthcare has reacquired
sublicense rights under more than 150 issued patents and more than 40 patent
applications for use in the diabetes field. These patents and patent
applications are now available for licensing to healthcare companies focused
on developing products and services for the management and/or monitoring of
individuals with chronic medical conditions, including diabetes. The Bosch
Healthcare patents include those which are directed at the collection of
insulin dosage information, blood glucose readings and other laboratory data
associated with diabetes management, monitoring and treatment.

According to Dr. Jasper zu Putlitz, M.D., president of Bosch Healthcare
Systems, “Diabetes impacts millions of Americans, of all ages. The need to
monitor and manage diabetes, and its symptoms continues to grow as does the
need to prevent the complications of diabetes. Bosch Healthcare seeks to work
with those companies that share our concern and are using innovation to help
manage diabetes and other chronic medical conditions.”

Companies interested in establishing a licensing agreement under Bosch
Healthcare patents should contact Greg Mathis.

About Robert Bosch Healthcare Systems, Inc.:

Robert Bosch Healthcare Systems, Inc., is a leading provider of innovative
telehealth systems. Bosch’s product spectrum ranges from patient interfaces to
comprehensive health management and patient evaluation software allowing
healthcare professionals to efficiently evaluate the patient’s health status.
Bosch Healthcare strives to help improve diagnosis and treatment through
systematic patient monitoring and involvement. The result is that health
professionals are able to provide a higher quality of care for patients with
chronic conditions, patients lead happier and healthier lives, and the cost of
healthcare is reduced for payers. Robert Bosch Healthcare Systems, Inc. is a
fully owned subsidiary of the Bosch Group. For more information, go to
www.bosch-telehealth.com.

About Bosch:

In the U.S., Canada and Mexico, the Bosch Group manufactures and markets
automotive original equipment and aftermarket solutions, industrial drives and
control technology, power tools, security and communication systems, packaging
technology, thermotechnology, household appliances, solar energy, healthcare
telemedicine and software solutions. Having established a regional presence in
1906, Bosch employs nearly 24,600 associates in more than 100 locations, with
consolidated sales of $10.6 billion in fiscal year 2012. For more information,
visit www.boschusa.com, www.bosch.com.mx and www.bosch.ca.

The Bosch Group is a leading global supplier of technology and services. In
fiscal 2012, its roughly 306,000 associates generated sales of $67.5 billion.
Since the beginning of 2013, its operations have been divided into four
business sectors: Automotive Technology, Industrial Technology, Consumer
Goods, and Energy and Building Technology. The Bosch Group comprises Robert
Bosch GmbH and its roughly 360 subsidiaries and regional companies in some 50
countries. If its sales and service partners are included, then Bosch is
represented in roughly 150 countries. This worldwide development,
manufacturing, and sales network is the foundation for further growth. Bosch
spent some $6.1 billion for research and development in 2012, and applied for
nearly 4,800 patents worldwide. The Bosch Group’s products and services are
designed to fascinate, and to improve the quality of life by providing
solutions which are both innovative and beneficial. In this way, the company
offers technology worldwide that is “Invented for life.” Additional
information is available online at www.bosch.com and www.bosch-press.com.

Contact:

Licensing Contact:
Robert Bosch Healthcare Systems, Inc.
Greg Mathis, +1 650-690-9103
Greg.Mathis@us.bosch.com
or
Media Contact:
Robert Bosch Healthcare Systems, Inc.
Bill Broderick, +1 650-690-9248
Bill.Broderick@us.bosch.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement